1 year return (CAGR)
-19.70%
Sage Therapeutics Inc Exchange (NASDAQ, USD)
SAGE
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-36.87%
5 year return (CAGR)
-28.75%
10 year return (CAGR)
-19.61%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
544.94M
Price/Sales
5.12
Ent value
515.91M
Price/Book
0.99
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
2.28%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 8.68 |
| Daily high | 8.68 |
| Daily low | 8.68 |
| Daily Volume | 0K |
| 1y analyst estimate | 8.58 |
| Beta | 0.30 |
| EPS (TTM) | -5.52 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| SAGE | S&P500 | |
| Current price drop from All-time high | -95.49% | -0.79% |
| Highest price drop | -97.51% | -56.47% |
| Date of highest drop | 19 Nov 2024 | 9 Mar 2009 |
| Avg drop from high | -53.83% | -10.68% |
| Avg time to new high | 54 days | 12 days |
| Max time to new high | 1883 days | 1805 days |
News
No items found